211 related articles for article (PubMed ID: 37015332)
21. New therapeutic strategies for squamous cell cancer and adenocarcinoma.
Wijnhoven BPL; Toxopeus ELA; Vallböhmer D; Knoefel WT; Krasna MJ; Perez K; van Rossum PSN; Ruurda JP; van Hillegersberg R; Schiesser M; Schneider P; Felix VN
Ann N Y Acad Sci; 2013 Oct; 1300():213-225. PubMed ID: 24117644
[TBL] [Abstract][Full Text] [Related]
22. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Resetkova E; Wang H; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Hamilton SR; Albarracin CT
Clin Cancer Res; 2006 Aug; 12(15):4598-604. PubMed ID: 16899607
[TBL] [Abstract][Full Text] [Related]
23. Esophagus and Gastrointestinal Junction Tumors.
Kurtom S; Kaplan BJ
Surg Clin North Am; 2020 Jun; 100(3):507-521. PubMed ID: 32402297
[TBL] [Abstract][Full Text] [Related]
24. Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers.
Strong VE; D'Amico TA; Kleinberg L; Ajani J
J Natl Compr Canc Netw; 2013 Jan; 11(1):60-6. PubMed ID: 23307982
[TBL] [Abstract][Full Text] [Related]
25. Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma.
Doi T; Piha-Paul SA; Jalal SI; Saraf S; Lunceford J; Koshiji M; Bennouna J
J Clin Oncol; 2018 Jan; 36(1):61-67. PubMed ID: 29116900
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy for Esophageal Adenocarcinoma.
Lam KO; Kwong DLW
Methods Mol Biol; 2018; 1756():19-34. PubMed ID: 29600357
[TBL] [Abstract][Full Text] [Related]
27. Distant Oncologic Outcome of Patients with Locally Advanced Unresectable and Metastatic Esophageal Cancer after Multimodality Treatment.
Anghel R; Constantinoiu S; Bacinschi X; Gales L; Toma RV; Trifanescu O
Chirurgia (Bucur); 2018; 113(1):116-122. PubMed ID: 29509538
[No Abstract] [Full Text] [Related]
28. Cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Surg Oncol; 2000 Jul; 9(1):35-41. PubMed ID: 11525305
[TBL] [Abstract][Full Text] [Related]
29. Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge?
Al-Batran SE; Lorenzen S
Hematol Oncol Clin North Am; 2017 Jun; 31(3):441-452. PubMed ID: 28501086
[TBL] [Abstract][Full Text] [Related]
30. Recent progress and current challenges of immunotherapy in advanced/metastatic esophagogastric adenocarcinoma.
Moehler M; Högner A; Wagner AD; Obermannova R; Alsina M; Thuss-Patience P; van Laarhoven H; Smyth E
Eur J Cancer; 2022 Nov; 176():13-29. PubMed ID: 36183651
[TBL] [Abstract][Full Text] [Related]
31. Multidisciplinary approach to esophageal and gastric cancer.
Stein HJ; Sendler A; Fink U; Siewert JR
Surg Clin North Am; 2000 Apr; 80(2):659-82; discussions 683-6. PubMed ID: 10836011
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer.
Smithers BM; Thomson I
Thorac Surg Clin; 2013 Nov; 23(4):509-23. PubMed ID: 24199701
[TBL] [Abstract][Full Text] [Related]
33. New directions in perioperative management of locally advanced esophagogastric cancer.
Burtness B; Ilson D; Iqbal S
Am Soc Clin Oncol Educ Book; 2014; ():e172-8. PubMed ID: 24857100
[TBL] [Abstract][Full Text] [Related]
34. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus.
Cameron AJ; Lomboy CT; Pera M; Carpenter HA
Gastroenterology; 1995 Nov; 109(5):1541-6. PubMed ID: 7557137
[TBL] [Abstract][Full Text] [Related]
35. [Pretherapeutic misclassification of esophageal cancer and adenocarcinoma of the esophagogastric junction : Possibilities and clinical consequences].
Gockel I; Lordick F; Lyros O; Kreuser N; Hölscher AH; Wittekind C
Chirurg; 2020 Jan; 91(1):41-50. PubMed ID: 31372677
[TBL] [Abstract][Full Text] [Related]
36. Gastroesophageal junction adenocarcinoma.
Swisher SG; Pisters PW; Komaki R; Lahoti S; Ajani JA
Curr Treat Options Oncol; 2000 Dec; 1(5):387-98. PubMed ID: 12057146
[TBL] [Abstract][Full Text] [Related]
37. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
Varadhachary G; Ajani JA
Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
[TBL] [Abstract][Full Text] [Related]
38. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy in esophagogastric cancer.
Ilson DH
Clin Adv Hematol Oncol; 2021 Oct; 19(10):639-647. PubMed ID: 34637430
[TBL] [Abstract][Full Text] [Related]
40. Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer.
Rice TW; Ishwaran H; Ferguson MK; Blackstone EH; Goldstraw P
J Thorac Oncol; 2017 Jan; 12(1):36-42. PubMed ID: 27810391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
